-
1
-
-
84871501913
-
-
Avis du Comité Technique des Vaccinations et du Conseil Supérieur d'hygiène Publique de France (section des maladies transmissibles) relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18 (séances du 9 mars
-
Avis du Comité Technique des Vaccinations et du Conseil Supérieur d'hygiène Publique de France (section des maladies transmissibles) relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18 (séances du 9 mars 2007).
-
(2007)
-
-
-
2
-
-
79959765563
-
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
-
Castellsague X., Munoz N., Pitisuttithum P., et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer 2011, 105:28-37.
-
(2011)
Br J Cancer
, vol.105
, pp. 28-37
-
-
Castellsague, X.1
Munoz, N.2
Pitisuttithum, P.3
-
3
-
-
84871494168
-
HPV 16/18 vaccine: Sustained immunogenicity and efficacy up to 9.4 years
-
Naud P., Roteli-Martins C.M., De Carvalho N., et al. HPV 16/18 vaccine: Sustained immunogenicity and efficacy up to 9.4 years. Abstract presented at the IPV Conference, Berlin Sept 2011, 17-22.
-
(2011)
Abstract presented at the IPV Conference, Berlin Sept
, pp. 17-22
-
-
Naud, P.1
Roteli-Martins, C.M.2
De Carvalho, N.3
-
4
-
-
84871482926
-
-
Gardasil European Public Assessment Report GARDASIL:
-
Gardasil European Public Assessment Report GARDASIL: http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000703/WC500021142.pdf.
-
-
-
-
5
-
-
84871506021
-
-
Cervarix European Public Assessment Report:
-
Cervarix European Public Assessment Report: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000721/WC500024632.pdf.
-
-
-
-
6
-
-
33846062024
-
-
ORS Ile de France, Paris
-
Beltzer N., Lagarde M., Wu-Zhou, et al. Les connaissances, attitudes, croyances et comportements face au VIH/sida en France 2005, ORS Ile de France, Paris.
-
(2005)
Les connaissances, attitudes, croyances et comportements face au VIH/sida en France
-
-
Beltzer, N.1
Lagarde, M.2
Wu-Zhou3
-
7
-
-
84871480792
-
-
http://www.inpes.sante.fr/30000/actus2012/027-hbsc.asp.
-
-
-
-
8
-
-
79955034694
-
HPV vaccination in France: uptake, costs and issues for the National Health Insurance
-
Fagot J.P., Boutrelle A., Ricordeau P., et al. HPV vaccination in France: uptake, costs and issues for the National Health Insurance. Vaccine 2011, 29:3610-3616.
-
(2011)
Vaccine
, vol.29
, pp. 3610-3616
-
-
Fagot, J.P.1
Boutrelle, A.2
Ricordeau, P.3
-
9
-
-
84861195608
-
Couverture vaccinale : Les ados en danger... Le point à l'occasion de la semaine de la vaccination
-
Cohen R., Denis F., Gaudelus J., et al. Couverture vaccinale : Les ados en danger... Le point à l'occasion de la semaine de la vaccination. Med Mal Infect 2012, 42:139-140.
-
(2012)
Med Mal Infect
, vol.42
, pp. 139-140
-
-
Cohen, R.1
Denis, F.2
Gaudelus, J.3
-
10
-
-
36749010976
-
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions
-
Siegrist C.A., Lewis E.M., Eskola J., et al. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr Infect Dis J 2007, 26:979-984.
-
(2007)
Pediatr Infect Dis J
, vol.26
, pp. 979-984
-
-
Siegrist, C.A.1
Lewis, E.M.2
Eskola, J.3
-
11
-
-
0029025444
-
Immunization with virus like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
-
Breitburd F., Kirnbauer R., Hubbert N.L., et al. Immunization with virus like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995, 69:3959-3963.
-
(1995)
J Virol
, vol.69
, pp. 3959-3963
-
-
Breitburd, F.1
Kirnbauer, R.2
Hubbert, N.L.3
-
12
-
-
0029610072
-
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
-
Suzich J.A., Ghim S.J., Palmer-Hill F.J., et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 1995, 92:11553-11557.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 11553-11557
-
-
Suzich, J.A.1
Ghim, S.J.2
Palmer-Hill, F.J.3
-
13
-
-
35348908938
-
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine
-
Giuliano A.R., Lazcano-Ponce E., Villa L., et al. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. J Infect Dis 2007, 196:1153-1162.
-
(2007)
J Infect Dis
, vol.196
, pp. 1153-1162
-
-
Giuliano, A.R.1
Lazcano-Ponce, E.2
Villa, L.3
-
14
-
-
34248631118
-
Immunization of early adolescent females with human papillomavirus type 6 and 18 L1 virus-like particle vaccine containing AS04 adjuvant
-
Pedersen C., Petaja T., Strauss G., et al. Immunization of early adolescent females with human papillomavirus type 6 and 18 L1 virus-like particle vaccine containing AS04 adjuvant. J Adolesc Health 2007, 40:564-571.
-
(2007)
J Adolesc Health
, vol.40
, pp. 564-571
-
-
Pedersen, C.1
Petaja, T.2
Strauss, G.3
-
15
-
-
84855184271
-
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule: Results from a randomized study
-
Romanowski B., Schwarz T.F., Ferguson L.M., et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule: Results from a randomized study. Hum Vaccin 2011, 7:1374-1386.
-
(2011)
Hum Vaccin
, vol.7
, pp. 1374-1386
-
-
Romanowski, B.1
Schwarz, T.F.2
Ferguson, L.M.3
-
16
-
-
79952567170
-
Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive luminex assays in a two-versus three-dose HPV vaccine trial
-
Krajden M., Cook D., Yu A., et al. Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive luminex assays in a two-versus three-dose HPV vaccine trial. Clin Vaccine Immunol 2011, 18:418-423.
-
(2011)
Clin Vaccine Immunol
, vol.18
, pp. 418-423
-
-
Krajden, M.1
Cook, D.2
Yu, A.3
-
17
-
-
84855330556
-
Success of HPV vaccination is now a matter of coverage
-
Schiffman M., Wacholder S. Success of HPV vaccination is now a matter of coverage. Lancet Oncol 2012, 13:10-12.
-
(2012)
Lancet Oncol
, vol.13
, pp. 10-12
-
-
Schiffman, M.1
Wacholder, S.2
-
18
-
-
84865012403
-
Vaccinoscopie : Couverture vaccinale vis à vis du méningo C
-
Gaudelus J., Cohen R., Lepetit H., et al. Vaccinoscopie : Couverture vaccinale vis à vis du méningo C. Médecine et Enfance 2011, 11:205-209.
-
(2011)
Médecine et Enfance
, vol.11
, pp. 205-209
-
-
Gaudelus, J.1
Cohen, R.2
Lepetit, H.3
-
19
-
-
84861742303
-
Human papillomavirus - associated cancers - United States 2004-2008
-
Centers for Disease Control and prevention (CDC)
-
Human papillomavirus - associated cancers - United States 2004-2008. MMWR Mord Mortal Wkly 2012, 61:258-261. Centers for Disease Control and prevention (CDC).
-
(2012)
MMWR Mord Mortal Wkly
, vol.61
, pp. 258-261
-
-
-
20
-
-
80054087108
-
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine
-
for the CVT Vaccine Group
-
Kreimer A.R., Rodriguez A.C., Hildesheim A., et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst 2011, 103:1444-1451. for the CVT Vaccine Group.
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1444-1451
-
-
Kreimer, A.R.1
Rodriguez, A.C.2
Hildesheim, A.3
-
21
-
-
84871494600
-
-
http://afssaps-prd.afssaps.fr/php/ecodex/rcp/R0134370.htm.
-
-
-
-
22
-
-
84871514532
-
-
Office fédéral de Santé publique - Plan de vaccination suisse
-
Office fédéral de Santé publique - Plan de vaccination suisse 2012 : http://www.bag.admin.ch/ekif/04423/04428/index.html%3Flang=frhttp%3A//www.bag.admin.ch/ekif/04423/04428/index.html%3Flang=fr.
-
(2012)
-
-
-
23
-
-
84871501914
-
-
Call for evidence to support HPV immunisation programme review
-
Call for evidence to support HPV immunisation programme review http://www.dh.gov.uk/health/2012/08/jcvi-hpv/.
-
-
-
-
24
-
-
84869811234
-
-
ECDC Guidance: Introduction of HPV vaccines in European Union countries - an update September
-
ECDC Guidance: Introduction of HPV vaccines in European Union countries - an update September 2012.
-
(2012)
-
-
|